Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmacogenomics and Personalized Medicine|October 21, 2016
Pharmacogenomics of statins: understanding susceptibility to adverse effectsJoseph P Kitzmiller, Eduard B Mikulik, Anees M Dauki, et al.Cancer Research|November 6, 2019
Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma ProgressionAnees M Dauki, James S Blachly, Esko A Kautto, et al.Cell Metabolism|April 12, 2015
GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individualsJasmine A Luzum, Joseph P Kitzmiller, Paul J Isackson, et al.CPT: Pharmacometrics & Systems Pharmacology|March 14, 2021
Approaches to handling missing or "problematic" pharmacology data: PharmacokineticsDonald J Irby, Mustafa E Ibrahim, Anees M Dauki, et al.Clinical and Translational Science|August 22, 2024
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participantsAnees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid TumorsAnthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, et al.Cancers|August 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular CarcinomaEmma J Hoelzen, Hanna S Radomska, Samuel K Kulp, et al.EMBO Molecular Medicine|January 14, 2020
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitorSophia G Liva, Yu-Chou Tseng, Anees M Dauki, et al.Pageof 1